Business
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Result...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen1{\nBORDER-TOP:0pt; BORDER-RIGHT:0pt; BORDER-COLLAPSE: COLLAPSE; BORDER-BOTTOM:0pt; BORDER-LEFT:0pt\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Sept. 12, 2019\n\n\n\nTSX:IN OTCQX:IMLFF\n VANCOUVER, Sept. 12, 2019 /CNW/ - InMed Pharmaceuticals Inc. (\"InMed\" or the \"Company\") (TSX: IN; OTCQX: IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases with high unmet medical needs, will report financial results for the three and twelve months ended June 30, 2019, which is the Company's fourth quarter of fiscal year 2019 (\"4Q19\"), on Thursday, September 19, 2019.\n\n \n \n\n \nConference Call & Webcast:\nThursday, September 19, 2019 at 7:00 AM Pacific Time, 10:00 AM Eastern Time\nLocal - Toronto\n(+1) 416 764 8688\nLocal - Vancouver\n(+1) 778 383 7413\nToll Free - North America\n(+1) 888 390 0546\nConference ID:\n69127515\nWebcast:  https://event.on24.com/wcc/r/2086245/D40B5BE6A8BF367A42BBE5A874673D56\n \nReplays, Available through September 26, 2019: \nToronto:\n(+1) 416 764 8677\nNorth America (Toll Free):\n(+1) 888 390 0541\nPlayback Passcode:\n127515 #\n \nThe Company's full financial statements and related MD&A for the three and twelve months ended June 30, 2019 will be available at www.sedar.com on September 19, 2019.\nAbout InMed: InMed Pharmaceuticals is a biopharmaceutical company developing a proprietary biosynthesis manufacturing techno...